Ronghui Lin

Ronghui Lin

Auto-generated profile, based on publicly available information

Ronghui Lin

Johnson & Johnson

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RLRonghui Lin
Ronghui Lin
SJSigmond G. Johnson
Sigmond G. Johnson
PCPeter J. Connolly
Peter J. Connolly
SWSteven K. Wetter
Steven K. Wetter
EBEva Binnun
Eva Binnun
SMSteven A. Middleton
Steven A. Middleton

1 August 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RLRonghui Lin
Ronghui Lin
PCPeter J. Connolly
Peter J. Connolly
YLYanhua Lu
Yanhua Lu
GCGeorge Chiu
George Chiu
SLShengjian Li
Shengjian Li
LGLee M. Greenberger
Lee M. Greenberger

18 July 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
ASAlex M. Shimozono
Alex M. Shimozono
JRJose B. Roque
Jose B. Roque
HLHaozheng Li
Haozheng Li
TZTianyi Zhang
Tianyi Zhang
RLRonghui Lin
Ronghui Lin
PCPaul J. Chirik
Paul J. Chirik

13 March 2009 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
RLRonghui Lin
Ronghui Lin
RSRhys Salter
Rhys Salter
YGYong Gong
Yong Gong

18 September 2017 in Journal of Labelled Compounds and Radiopharmaceuticals
Verified
Journal Article
Closed access
PDF file
RLRonghui Lin
Ronghui Lin
DHDavid C. Hoerr
David C. Hoerr
LWLarry E. Weaner
Larry E. Weaner
RSRhys Salter
Rhys Salter

22 April 2026 in ACS Catalysis
Verified
Journal Article
Open access
ASAlex M. Shimozono
Alex M. Shimozono
HLHaozheng Li
Haozheng Li
SBShubham Bisht
Shubham Bisht
BKBuddha B. Khatri
Buddha B. Khatri
LCLu Chen
Lu Chen
PCPaul J. Chirik
Paul J. Chirik
Treatment of K2[Co2(OtBu)6] with a series of imidazolium salts, RACNC-(HBr)2, provided a route to sterically modified t-butoxide-bridged cobalt compounds, (RACNC)Co2(OtBu)4 (RACNC = N-alkyl-substituted pyridine dicarbene). Characterization by X-ray diffraction and SQUID magnetometry established non-interacting and high-spin dicobalt structures with bridging and terminal alkoxide ligands where the ACNC pincer spans both idealized tetrahedral cobalt atoms. In the presence of excess tert-butyl ethylene (TBE) and B2Pin2, the (RACNC)Co2(OtBu)4, derivatives served as precatalysts for the borylation of electron-rich arenes. Side-by-side comparison enabled the identification of a second-generation pre-catalyst, (EtACNC)Co2(OtBu)4, which displayed improved activity for the borylation of substrates bearing large R groups and aryl-CH3 groups and improved meta selectivity for phenol, aniline, and alkyl benzene derivatives. When applied to biologically active molecules, 11 late-stage functionalizations were achieved, followed by a series of hydroxylations and deuterations, highlighting the application of the developed precatalysts for pharmaceutical research and development. In operando monitoring of the catalytic borylation and the observed site selectivities support formation of monomeric, pincer-supported cobalt(I) complexes as the active catalyst.